INDENTURE Dated as of May 17, 2024 among ORGANON & CO., as Issuer, ORGANON FOREIGN DEBT CO-ISSUER B.V., as Co-Issuer, and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee, 7.875% SENIOR NOTES DUE 2034Indenture • May 17th, 2024 • Organon & Co. • Pharmaceutical preparations • New York
Contract Type FiledMay 17th, 2024 Company Industry Jurisdiction
INDENTURE Dated as of May 17, 2024 among ORGANON & CO., as Issuer, ORGANON FOREIGN DEBT CO-ISSUER B.V., as Co-Issuer, and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee and Collateral Agent, 6.750% SENIOR SECURED NOTES DUE 2034Indenture • May 17th, 2024 • Organon & Co. • Pharmaceutical preparations • New York
Contract Type FiledMay 17th, 2024 Company Industry JurisdictionThis INDENTURE, dated as of May 17, 2024, is among Organon & Co., a Delaware corporation (the “Issuer”), Organon Foreign Debt Co-Issuer B.V., a private limited liability company incorporated under the laws of the Netherlands (besloten vennootschap met beperkte aansprakelijkheid) having its official seat (statutaire zetel) in Oss, The Netherlands, having its registered office at Kloosterstraat 6, 5349 AB Oss, The Netherlands, and registered with the trade register of the Dutch Chamber of Commerce (Kamer van Koophandel) under number 82563098 (the “Co-Issuer” and, together with the Issuer, the “Issuers”), the Guarantors (as defined herein) and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) and as collateral agent (the “Collateral Agent”).